- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | 60% of online searches lead to counterfeit meds | ||
| Mo | GSK to divest Rabipur, Encepur to Bavarian Nordic | ||
| Mo | Cancer Research UK sets 'bold' research ambition | ||
| Mo | CHMP approves first Ebola vaccine, six other medicines | ||
| Mo | QiC Diabetes awards 2019 results announced | ||
| Fr | 56% rise in GPs seeking mental health help in last year | ||
| Fr | BMS, Pfizer turn to Fitbit for atrial fibrillation detection | ||
| Fr | Xofluza bags FDA approval for flu complications | ||
| Fr | CHMP U-turn for Evenity | ||
| Do | Clinigen launches programme to provide Azedra outside US | ||
| Do | Chiesi announces two successful sets of asthma data | ||
| Do | Genetic Parkinson's cohorts 'urgently' need identifying | ||
| Do | Gov awards urgent meds freight contracts | ||
| Mi | Just two weeks left until MSEA closes for entry! | ||
| Mi | Obesity levels of four and five-year-olds rose 9.5% last year | ||
| Mi | Ambulance staff to access patient mental health crisis plans | ||
| Mi | Investigational atopic dermatitis drug hits late-stage endpoints | ||
| Mi | Review recommends screening upgrade to save more lives | ||
| 15.10. | Pfizer launches 'catfish' counterfeit medicines campaign | ||
| 15.10. | FDA 'yes' for Eli Lilly's Reyvow | ||
| 15.10. | Survey reveals 'workforce crisis' in NHS | ||
| 15.10. | Tailor-made drug shows success in Batten disease | ||
| 14.10. | Rituxan hits targets in late-stage pemphigus vulgaris trial | ||
| 14.10. | Novo, Bluebird Bio ink in vivo genome research agreement | ||
| 14.10. | NHS to improve young people's hospital mental health, learning disability and autism services |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
